Literature DB >> 30082175

Development and validation of a nomogram for predicting survival in patients with gastrointestinal stromal tumours.

Wei Song1, Chang-Guang Lv1, Dong-Liu Miao1, Zhi-Gang Zhu1, Qiong Wu1, Yong-Gang Wang1, Lei Chen2.   

Abstract

BACKGROUND: This study aimed to develop and validate nomograms for predicting long-term overall survival (OS) and cancer-specific survival (CSS) in gastrointestinal stromal tumours (GISTs).
METHODS: Patients diagnosed with GISTs between 2004 and 2015 were selected for the study from the Surveillance, Epidemiology, and End Results (SEER) database. Patients were randomly separated into the training set and the validation set. Multivariate analysis was used on the training set to obtain independent prognostic factors to build nomograms for predicting 3- and 5-year OS and CSS. The discrimination and calibration plots were used to evaluate the predictive accuracy of the nomograms.
RESULTS: Data for a total of 5622 patients with GISTs were collected from the SEER database. Nomograms were established based on variables that were significantly associated with OS and CSS identified by the Cox regression model. The nomograms for predicting OS and CSS displayed better discrimination power than did the SEER stage and Tumour-Node-Metastasis (TNM) staging systems (7th edition) in the training set and validation set. Calibration plots of the nomograms indicated that OS and CSS closely corresponded to actual observation.
CONCLUSIONS: The nomograms were able to more accurately predict 3- and 5-year OS and CSS of patients with GISTs than were existing models.
Copyright © 2018 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Cancer-specific survival; Gastrointestinal stromal tumours; Nomogram; Overall survival

Mesh:

Year:  2018        PMID: 30082175     DOI: 10.1016/j.ejso.2018.07.004

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  21 in total

1.  Development and validation of prognostic nomograms for patients with metastatic prostate cancer.

Authors:  Wei-Dong Jiang; Ping-Cheng Yuan
Journal:  Int Urol Nephrol       Date:  2019-07-09       Impact factor: 2.370

2.  Development and validation of prognostic nomogram for young patients with gastric cancer.

Authors:  Chaoran Yu; Yujie Zhang
Journal:  Ann Transl Med       Date:  2019-11

3.  High expression of VCAN is an independent predictor of poor prognosis in gastric cancer.

Authors:  Wenfei Li; Fang Han; Min Fu; Zhanqiu Wang
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

4.  Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer.

Authors:  Jian-Dong Diao; Li-Xia Ma; Mei-Yang Sun; Chun-Jiao Wu; Li-Juan Wang; Yan-Ling Liu; Yong-Jing Yang
Journal:  Cancer Med       Date:  2019-08-12       Impact factor: 4.452

5.  Development and validation of a prognostic nomogram for early-onset colon cancer.

Authors:  Chaoran Yu; Yujie Zhang
Journal:  Biosci Rep       Date:  2019-06-20       Impact factor: 3.840

6.  Clinical characteristics and disease-specific prognostic nomogram for primary gliosarcoma: a SEER population-based analysis.

Authors:  Song-Shan Feng; Huang-Bao Li; Fan Fan; Jing Li; Hui Cao; Zhi-Wei Xia; Kui Yang; Xiao-San Zhu; Ting-Ting Cheng; Quan Cheng
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

7.  A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery.

Authors:  Xin Chai; Mei-Yang Sun; Hong-Yao Jia; Min Wang; Ling Cao; Zhi-Wen Li; Dun-Wei Wang
Journal:  PeerJ       Date:  2019-10-14       Impact factor: 2.984

8.  Nomograms for predicting long-term overall survival and cancer-specific survival in lip squamous cell carcinoma: A population-based study.

Authors:  Chuan-Yu Hu; Zhen-Yu Pan; Jin Yang; Xiu-Hong Chu; Jun Zhang; Xue-Jin Tao; Wei-Min Chen; Yuan-Jie Li; Jun Lyu
Journal:  Cancer Med       Date:  2019-05-21       Impact factor: 4.452

9.  Long-term survival among patients with gastrointestinal stromal tumors diagnosed after another malignancy: a SEER population-based study.

Authors:  Chaoyong Shen; Chengshi Wang; Tao He; Zhaolun Cai; Xiaonan Yin; Yuan Yin; Donghao Lu; Bo Zhang; Zongguang Zhou
Journal:  World J Surg Oncol       Date:  2020-05-06       Impact factor: 2.754

10.  A sample model established by S-index predicting overall survival after curative resection of primary hepatocellular carcinoma.

Authors:  Lei Chen; Bin-Bin Cai; Chao-Jun Zhou; Xiang-Qing Hou; Si-Pin Hu; Guan Fang; Wen-Chao Chen; Lin-Hui Li; Wen-Jun Yang
Journal:  Cancer Manag Res       Date:  2019-01-14       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.